WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 9 fonti

New daily weight loss pill helps people shed 10 per cent of body weight

The pill doesn’t have the fasting requirements of many other weight loss drugs

Raccontata damorningstar.comendpoints.newsdailymail.comeluniversal.com.mxpublico.ptfrance24.commedpagetoday.combenzinga.comindependent.co.uk

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
independent.co.ukStai leggendo5 g fa

New daily weight loss pill helps people shed 10 per cent of body weight

The pill doesn’t have the fasting requirements of many other weight loss drugs

originale
france24.com6 g fa

Encouraging trial results for AstraZeneca's new weight-loss pill

A new pill developed by the British pharma firm AstraZeneca appears to help people lose a similar amount of weight to other GLP-1 oral drugs, trial results showed Monday.

Leggi questa versione → originale
dailymail.com6 g fa

New daily pill helps obese patients lose a tenth of bodyweight

An experimental daily weight loss pill helped people shift more than ten per cent of their bodyweight after six months, research has found.

Leggi questa versione → originale
medpagetoday.com5 g fa

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

Investigational pill was well-tolerated and doesn't come with food or water restrictions

Leggi questa versione → originale
morningstar.com6 g fa

Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

Leggi questa versione → originale
benzinga.com5 g fa

AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials - AstraZeneca (NYSE:AZN)

AstraZeneca advances oral GLP-1 elecoglipron to Phase 3 following strong weight loss & diabetes data at ADA 2026. Get the trial details.

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 8 giugno 2026·morningstar.com

    Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

    Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

  2. lunedì 8 giugno 2026·endpoints.news

    AstraZeneca's obesity pill matches rivals in Phase 2, anchoring $5B franchise push

    AstraZeneca's oral GLP-1 elecoglipron cut weight up to 10.5% in Phase 2, as AZ launches multiple Phase 3 trials targeting a $5B obesity franchise.

  3. lunedì 8 giugno 2026·dailymail.com

    New daily pill helps obese patients lose a tenth of bodyweight

    An experimental daily weight loss pill helped people shift more than ten per cent of their bodyweight after six months, research has found.

  4. lunedì 8 giugno 2026·eluniversal.com.mx

    AstraZeneca se suma al mercado contra la obesidad, nueva pastilla da resultados alentadores en ensayo clínico

    Especialistas consideran que el medicamento merece evaluaciones más amplias antes de solicitar su autorización

  5. martedì 9 giugno 2026·publico.pt

    Comprimido da AstraZeneca para a obesidade ajuda doentes a perder 10,5% do peso

    Doentes perderam 10,5% do peso em 26 semanas num ensaio intermédio da pílula experimental da AstraZeneca, que quer disputar o mercado do emagrecimento com a Novo Nordisk e a Eli…

  6. martedì 9 giugno 2026·france24.com

    Encouraging trial results for AstraZeneca's new weight-loss pill

    A new pill developed by the British pharma firm AstraZeneca appears to help people lose a similar amount of weight to other GLP-1 oral drugs, trial results showed Monday.

  7. martedì 9 giugno 2026·medpagetoday.com

    Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

    Investigational pill was well-tolerated and doesn't come with food or water restrictions

  8. martedì 9 giugno 2026·benzinga.com

    AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials - AstraZeneca (NYSE:AZN)

    AstraZeneca advances oral GLP-1 elecoglipron to Phase 3 following strong weight loss & diabetes data at ADA 2026. Get the trial details.

  9. mercoledì 10 giugno 2026·independent.co.uk

    New daily weight loss pill helps people shed 10 per cent of body weight

    The pill doesn’t have the fasting requirements of many other weight loss drugs

  10. mercoledì 10 giugno 2026·independent.co.uk

    AstraZeneca daily pill shows promising weight loss results in trial

    Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…